Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
October 29, 2019 at 01:55 pm IST
Share
Hunan Jiudian Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 659.474 million compared to CNY 561.335 million a year ago. Operating income was CNY 43.516 million compared to CNY 48.966 million a year ago. Net income was CNY 37.856 million compared to CNY 44.420 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.19 a year ago.
Hunan Jiudian Pharmaceutical Co Ltd is a company mainly engaged in research and development, production and sales of pharmaceutical preparations. The Companyâs products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The Company sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.
HUNAN JIUDIAN PHARMACEUTICAL CO., LTD. 
